ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Chicago, IL, USA:

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

effectiveness of the NanoKnife System when used to ablate localized prostate cancer in intermediate risk subjects with organ-confin ...

Active, not recruiting
Prostate Cancer
Device: NanoKnife Procedure
AngioDynamics
AngioDynamics

Chicago, Illinois, United States and 1 other location

The study is an open-label Phase 1 study of the combination of relacorilant with enzalutamide in patients with metastatic castration resistant prostate...

Enrolling
Prostate Cancer
Drug: Enzalutamide
Drug: Relacorilant

Phase 1

The University of Chicago
The University of Chicago

Chicago, Illinois, United States

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Chicago, Illinois, United States and 107 other locations

The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer...

Enrolling
Localized Prostate Cancer
Device: Robotic Waterjet Treatment
PROCEPT BioRobotics

Glenview, Illinois, United States and 3 other locations

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Biological: aglatimagene besadenovec

Phase 2

Candel Therapeutics

Chicago, Illinois, United States and 22 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Enrolling
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Hines, Illinois, United States and 8 other locations

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate...

Enrolling
Benign Prostatic Hyperplasia
Localized Prostate Cancer
Device: Robotic Waterjet Treatment
PROCEPT BioRobotics

Glenview, Illinois, United States and 3 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Enrolling
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Arvinas
Arvinas

Chicago, Illinois, United States and 22 other locations

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110

Phase 1, Phase 2

Arvinas
Arvinas

Chicago, Illinois, United States and 53 other locations

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Chicago, Illinois, United States and 11 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems